SB39-0921 Screening compound: N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-6,10-diazaspiro[4.6]undec-8-yl}methanesulfonamide

SB39-0921 Screening compound: N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-6,10-diazaspiro[4.6]undec-8-yl}methanesulfonamide
SB39-0921 Screening compound: N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-6,10-diazaspiro[4.6]undec-8-yl}methanesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SB39-0921
N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-6,10-diazaspiro[4.6]undec-8-yl}methanesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SB39-0921

Molecular Formula

C21H30N4O4S (C21 H30 N4 O4 S)

Compound Name

N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-6,10-diazaspiro[4.6]undec-8-yl}methanesulfonamide

IUPAC name

N-{10-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-7-oxo-610-diazaspiro[4.6]undecan-8-yl}methanesulfonamide

SMILES

Cn1c(ccc(OC)c2)c2c(CN(CC2NS(C)(=O)=O)CC3(CCCC3)NC2=O)c1

InChI

InChI=1S/C21H30N4O4S/c1-24-11-15(17-10-16(29-2)6-7-19(17)24)12-25-13-18(23-30(3,27)28)20(26)22-21(14-25)8-4-5-9-21/h6-7,10-11,18,23H,4-5,8-9,12-14H2,1-3H3,(H,22,26)/t18-/m0/s1

InChI Key

HVHJVXSFPLLHMR-SFHVURJKSA-N

MDL Number (MFCD)

MFCD32247574

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.259

Distribution Coefficient, logD

1.156

Water Solubility, LogSw

-2.45

Polar Surface Area

83.269

Acid Dissociation Constant (pKa)

11.44

Base Dissociation Constant (pKb)

6.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.14

SB39-0921 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS Targets (44014 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with SB39-0921 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SB39-0921?
Check Price and Availability of SB39-0921, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SB39-0921 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SB39-0921
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SB39-0921
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SB39-0921 available by request